Net Deals Web Search

  1. Ads

    related to: alcon novartis coupon for ciprodex 10 mg ml concentration

Search results

  1. Results From The WOW.Com Content Network
  2. Ciprofloxacin/dexamethasone - Wikipedia

    en.wikipedia.org/wiki/Ciprofloxacin/dexamethasone

    Ciprodex, owned by Alcon Laboratories, Inc., is protected by multiple patents and will be restricted from generic manufacturing until 2025. [6] [7] Ciprodex is the number 1 topical antibiotic ear drop prescribed since 2007 by ENTs and pediatricians.

  3. Ciprofloxacin - Wikipedia

    en.wikipedia.org/wiki/Ciprofloxacin

    Ciprofloxacin is 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7- (1-piperazinyl)-3-quinolinecarboxylic acid. Its empirical formula is C 17 H 18 FN 3 O 3 and its molecular weight is 331.4 g/mol. It is a faintly yellowish to light yellow crystalline substance.

  4. Alcon - Wikipedia

    en.wikipedia.org/wiki/Alcon

    Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. [3] [4] Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals , focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies.

  5. Novartis Obtains Final Shares of Alcon for $12.9 Billion - AOL

    www.aol.com/2010/12/15/novartis-obtains-final...

    Shares of Novartis (NVS) soared higher on Wednesday, after the Swiss drug maker finally obtained the remaining outstanding shares of Alcon (ACL) for $12.9 billion. Novartis had been trying to gain ...

  6. Novartis Completes Purchase of Alcon Majority Stake ... - AOL

    www.aol.com/news/2010-08-26-novartis-alcon-buy...

    The total cost to Novartis for the 77% stake in Alcon was $38.7 billion ($168 per share). In the deal's first phase, Novartis acquired a 25% stake in Alcon from Nestlé for $10.4 billion in July 2008.

  7. Novartis Aims to Beat $1.9B in Cost Savings By Year's End - AOL

    www.aol.com/2011/09/13/novartis-aims-to-beat-19b...

    The eye-care acquisition, which cost Novartis $51 billion, will deliver high single-digit to low double-digit sales growth, plus $350 million in cost It now expects more bang for its buck from Alcon.

  1. Ads

    related to: alcon novartis coupon for ciprodex 10 mg ml concentration